A pharmaceutical composition of nanoparticles

摘要

The invention discloses a pharmaceutical composition of bioactive nanoparticles composed of chitosan, enzyme-resistant PGA-complexone, and a bioactive agent for oral delivery. The chitosan-based nanoparticles are characterized with a positive surface charge, enhanced permeability, and enzyme resistance in the GIT for oral drug delivery.